Document:

EXHIBIT 10.2
                          REGISTRATION RIGHTS AGREEMENT

      AGREEMENT dated as of January 18, 2005,  between  MERCATOR  MOMENTUM FUND,
L.P., MERCATOR MOMENTUM FUND III, L.P, MONARCH POINTE FUND, LTD.  (collectively,
the  "Funds") and MERCATOR  ADVISORY  GROUP,  LLC ("MAG") (the Funds and MAG are
referred to individually as a "Holder" and  collectively as the "Holders"),  and
GeneThera, Inc., a Florida corporation (the "Company").

      WHEREAS,  the Funds have  purchased,  for an aggregate of  $1,100,000,  an
aggregate of 11,000 shares of Series A Convertible  Preferred Stock (the "Series
A Stock") from the Company,  and have the right to cause their Series A Stock to
be converted into shares of Common Stock,  $.001 par value (the "Common Stock"),
of the Company,  pursuant to the conversion formula set forth in the Certificate
of Determination;

      WHEREAS,  each  Fund  and  MAG  have  acquired  Warrants  (together,   the
"Warrants")  from the  Company,  pursuant to which the Holders have the right to
purchase in the  aggregate up to 597,826  shares of the Common Stock through the
exercise of the Warrants;

      WHEREAS,  the Company  desires to grant to the  Holders  the  registration
rights set forth herein with respect to the shares of Common Stock issuable upon
the conversion of the Series A Stock and the exercise of the Warrants.

      NOW, THEREFORE, the parties hereto mutually agree as follows:

      1. REGISTRABLE SECURITIES. As used herein the terms "Registrable Security"
means each of the shares of Common Stock (i) issued upon the  conversion  of the
Series A Stock (the  "Conversion  Shares") or (ii) upon exercise of the Warrants
(the "Warrant Shares"),  provided,  however, that with respect to any particular
Registrable  Security,  such security  shall cease to be a Registrable  Security
when,  as of  the  date  of  determination  that  (a) it  has  been  effectively
registered under the Securities Act of 1933, as amended (the "Securities  Act"),
and disposed of pursuant thereto,  or (b) registration  under the Securities Act
is no longer  required for the immediate  public  distribution of such security.
The term "Registrable Securities" means any and/or all of the securities falling
within the foregoing definition of a "Registrable Security." In the event of any
merger,  reorganization,  consolidation,  recapitalization  or other  change  in
corporate structure affecting the Common Stock, such adjustment shall be made in
the definition of  "Registrable  Security" as is appropriate in order to prevent
any dilution or enlargement of the rights granted pursuant to this Section 1.

      2. REGISTRATION.

            (a)  The  Company   shall  file  a   registration   statement   (the
"Registration  Statement")  with the  Securities  and Exchange  Commission  (the
"SEC") within  forty-five (45) days after the date of this Agreement in order to
register the resale of the Registrable Securities under the Securities Act. Once
effective,  the Company shall  maintain the  effectiveness  of the  Registration
Statement  until  the  earlier  of (i)  the  date  that  all of the  Registrable
Securities have been sold, or (ii) the date that the Company receives an opinion
of counsel to the Company that all of the  Registrable  Securities may be freely
traded without registration under the Securities Act, under Rule 144 promulgated
under the Securities Act or otherwise.
<PAGE>

            (b) The Company will initially include in the Registration Statement
as Registrable  Securities Two Million Seven Hundred Ninety-Seven Thousand Eight
Hundred Twenty-Six (2,797,826) shares of Common Stock.

      3. COVENANTS OF THE COMPANY WITH RESPECT TO REGISTRATION.

      The Company covenants and agrees as follows:

            (a) The  Company  shall use best  efforts to cause the  Registration
Statement  to become  effective  with the SEC as promptly as possible  and in no
event more than 120 days after the initial filing of the Registration  Statement
with the SEC.  If any  stop  order  shall  be  issued  by the SEC in  connection
therewith,  the Company shall use best efforts to obtain promptly the removal of
such order.  Following the effective  date of the  Registration  Statement,  the
Company shall, upon the request of any Holder,  forthwith supply such reasonable
number of copies  of the  Registration  Statement,  preliminary  prospectus  and
prospectus  meeting  the  requirements  of the  Securities  Act,  and any  other
documents  necessary or  incidental  to the public  offering of the  Registrable
Securities,  as shall be reasonably requested by the Holder to permit the Holder
to make a  public  distribution  of the  Holder's  Registrable  Securities.  The
obligations of the Company  hereunder  with respect to the Holder's  Registrable
Securities  are  subject  to  the  Holder's   furnishing  to  the  Company  such
appropriate   information   concerning  the  Holder,  the  Holder's  Registrable
Securities and the terms of the Holder's offering of such Registrable Securities
as the Company may reasonably request in writing.

            (b) The Company shall pay all costs, fees and expenses in connection
with the  Registration  Statement filed pursuant to Section 2 hereof  including,
without limitation,  the Company's legal and accounting fees, printing expenses,
and blue sky fees and  expenses;  provided,  however,  that each Holder shall be
solely  responsible  for the  fees of any  counsel  retained  by the  Holder  in
connection  with  such  registration  and any  transfer  taxes  or  underwriting
discounts,  commissions or fees applicable to the Registrable Securities sold by
the Holder pursuant thereto.

            (c) The  Company  will take all  actions  which may be  required  to
qualify or register  the  Registrable  Securities  included in the  Registration
Statement  for the offer and sale under the  securities or blue sky laws of such
states as are reasonably  requested by each Holder of such securities,  provided
that the Company  shall not be obligated to execute or file any general  consent
to service of process  or to  qualify as a foreign  corporation  to do  business
under the laws of any such jurisdiction.

      4. ADDITIONAL TERMS.

            (a) The Company  shall  indemnify  and hold harmless the Holders and
each  underwriter,  within the meaning of the  Securities  Act, who may purchase
from or sell for any Holder,  any Registrable  Securities,  from and against any
and all losses,  claims,  damages and liabilities caused by any untrue statement
of  a  material  fact  contained  in  the  Registration  Statement,   any  other
registration  statement  filed by the  Company  under  the  Securities  Act with
respect to the registration of the Registrable  Securities,  any  post-effective
amendment to such registration statements, or any prospectus included therein or
caused by any omission to state  therein a material  fact  required to be stated
therein or  necessary  to make the  statements  therein not  misleading,  except
insofar as such losses,  claims,  damages or liabilities  are caused by any such
untrue statement or omission based upon information  furnished or required to be
furnished in writing to the Company by the Holders or underwriter  expressly for
use therein,  which  indemnification  shall  include  each  person,  if any, who
controls any Holder or underwriter  within the meaning of the Securities Act and
each  officer,  director,  employee  and agent of each  Holder and  underwriter;
provided, however, that the indemnification in this Section 4(a) with respect to
any prospectus  shall not inure to the benefit of any Holder or underwriter  (or
to the benefit of any person  controlling  any Holder or underwriter) on account
of any  such  loss,  claim,  damage  or  liability  arising  from  the  sale  of
Registrable  Securities by the Holder or underwriter,  if a copy of a subsequent
prospectus   correcting  the  untrue  statement  or  omission  in  such  earlier
prospectus  was provided to such Holder or  underwriter  by the Company prior to
the subject sale and the subsequent  prospectus was not delivered or sent by the

                                       2
<PAGE>

Holder or underwriter to the purchaser prior to such sale and provided  further,
that the Company  shall not be obligated to so indemnify  any Holder or any such
underwriter  or other person  referred to above unless the Holder or underwriter
or other  person,  as the case may be,  shall  at the same  time  indemnify  the
Company, its directors, each officer signing the Registration Statement and each
person,  if any, who controls the Company  within the meaning of the  Securities
Act, from and against any and all losses, claims, damages and liabilities caused
by any  untrue  statement  of a  material  fact  contained  in the  Registration
Statement,  any registration statement or any prospectus required to be filed or
furnished by reason of this Agreement or caused by any omission to state therein
a  material  fact  required  to be  stated  therein  or  necessary  to make  the
statements therein not misleading,  insofar as such losses,  claims,  damages or
liabilities  are  caused  by  any  untrue   statement  or  omission  based  upon
information  furnished  in writing to the  Company by the Holder or  underwriter
expressly for use therein.

            (b)  If for  any  reason  the  indemnification  provided  for in the
preceding section is held by a court of competent jurisdiction to be unavailable
to an indemnified  party with respect to any loss, claim,  damage,  liability or
expense  referred  to  therein,   then  the  indemnifying   party,  in  lieu  of
indemnifying such indemnified  party thereunder,  shall contribute to the amount
paid or payable by the indemnified party as a result of such loss, claim, damage
or liability in such  proportion as is appropriate to reflect the relative fault
of the  indemnified  party  and the  indemnifying  party,  as well as any  other
relevant equitable considerations.

            (c) Neither the filing of a  Registration  Statement  by the Company
pursuant to this Agreement nor the making of any request for prospectuses by the
Holder  shall  impose  upon any  Holder  any  obligation  to sell  the  Holder's
Registrable Securities.

            (d) Each  Holder,  upon  receipt of notice from the Company  that an
event has occurred which requires a Post-Effective Amendment to the Registration
Statement or a supplement to the  prospectus  included  therein,  shall promptly
discontinue the sale of Registrable  Securities until the Holder receives a copy
of a  supplemented  or amended  prospectus  from the Company,  which the Company
shall provide as soon as practicable after such notice.

            (e) If the Company fails to keep the Registration Statement referred
to above  continuously  effective during the requisite period,  then the Company
shall,  promptly upon the request of any Holder,  use best efforts to update the
Registration  Statement  or  file  a new  registration  statement  covering  the
Registrable  Securities  remaining  unsold,  subject to the terms and provisions
hereof.

                                       3
<PAGE>

            (f) Each Holder  agrees to provide the Company with any  information
or undertakings  reasonably requested by the Company in order for the Company to
include any appropriate  information  concerning the Holder in the  Registration
Statement  or in order to promote  compliance  by the Company or the Holder with
the Securities Act.

            (g) The Company  agrees  that it shall cause each of its  directors,
officers  and  shareholders  owning ten percent  (10%) or more of the  Company's
outstanding  Common Stock to refrain  from  selling any shares of the  Company's
Common Stock until the Registration Statement has been declared effective.

            (h) Each  Holder,  on behalf of itself  and its  affiliates,  hereby
covenants  and agrees not to,  directly or  indirectly,  offer to "short  sell",
contract  to  "short  sell" or  otherwise  "short  sell" any  securities  of the
Company,  including,  without  limitation,  shares of Common  Stock that will be
received as a result of the  conversion of the Series A Stock or the exercise of
the Warrants.

      5. ADDITIONAL REGISTRATION. In the event that the Market Price (as defined
in the Articles of Amendment)  of the Company's  Common Stock shall be less than
$0.50,  then  within 45 days  after  receipt of written  notice  from  Holder (a
"Registration  Notice"),  the  Company  shall  file an  additional  registration
statement with the SEC to register a number of shares of Registrable  Securities
calculated by dividing $1,100,000 by the difference between $0.50 and the Market
Price of the Common  Stock on the date the  Registration  Notice is  received by
Company.

      6. GOVERNING LAW. The Registrable  Securities will be, if and when issued,
delivered in California.  This  Agreement  shall be deemed to have been made and
delivered  in the State of  California  and shall be  governed  as to  validity,
interpretation,  construction,  effect and in all other respects by the internal
substantive laws of the State of California, without giving effect to the choice
of law rules thereof.

      7. AMENDMENT.  This Agreement may only be amended by a written  instrument
executed by the Company and the Holders.

      8. ENTIRE AGREEMENT.  This Agreement along with the Subscription Agreement
of  even  date  herewith  (the  "Subscription  Agreement"  and  the  Transaction
Documents  (as defined in the  Subscription  Agreement)  constitutes  the entire
agreement of the parties hereto with respect to the subject  matter hereof,  and
supersedes all prior  agreements  and  understandings  of the parties,  oral and
written, with respect to the subject matter hereof.

      9.  EXECUTION IN  COUNTERPARTS.  This  Agreement may be executed in one or
more counterparts,  each of which shall be deemed an original,  but all of which
together shall constitute one and the same document.

      10. NOTICES. All communications hereunder shall be in writing and shall be
hand delivered, mailed by first-class mail, couriered by next-day air courier or
by facsimile at the addresses set forth below.

                                       4
<PAGE>

                  If to the Holders,     Mercator Advisory Group, LLC
                                         Mercator Momentum Fund, L.P.
                                         Mercator Momentum Fund III, L.P.
                                         Monarch Pointe Fund, Ltd.
                                         555 South Flower Street, Suite 4200
                                         Los Angeles, CA  90071
                                         Attention: David Firestone

                  With a copy to         Sheppard Mullin Richter & Hampton LLP
                                         333 South Hope Street
                                         48th Floor
                                         Los Angeles, CA 90071-1448
                                         Telephone No.: (213) 620-1780
                                         Facsimile No.:  (213) 620-1398
                                         Attention:        David C. Ulich

                  If to the Company,     GeneThera, Inc.
                                         3930 Youngfield Street
                                         Wheat Ridge, CO  80033
                                         Attention:  Antonio Milici
                                         Telephone:  (303) 463-6371
                                         Facsimile:   (303) 463-6377

                  With a copy to         Kendall, Koenig & Oelsner PC
                                         1675 Broadway, Suite 750
                                         Denver, CO  80202
                                         Telephone No.: (303) 672-0100
                                         Facsimile No.:  (303) 672-0101
                                         Attention:  Nathan E. Seiler

All such notices and communications shall be deemed to have been duly given: (i)
when delivered by hand, if personally  delivered;  (ii) five business days after
being deposited in the mail,  postage prepaid,  if mailed certified mail, return
receipt  requested;  (iii) one business  day after being  timely  delivered to a
next-day  air  courier  guaranteeing  overnight  delivery;   (iv)  the  date  of
transmission if sent via facsimile to the facsimile  number as set forth in this
Section or the  signature  page hereof prior to 4:00 p.m. on a business  day, or
(v) the business day following the date of transmission if sent via facsimile at
a facsimile  number set forth in this  Section or on the  signature  page hereof
after  4:00 p.m.  or on a date that is not a business  day.  Change of a party's
address or facsimile number may be designated  hereunder by giving notice to all
of the other parties hereto in accordance with this Section.

      11. BINDING EFFECT;  BENEFITS. Any Holder may assign its rights hereunder.
This  Agreement  shall inure to the benefit of, and be binding upon, the parties
hereto  and  their  respective  heirs,  legal  representatives,  successors  and
assigns.  Nothing herein  contained,  express or implied,  is intended to confer
upon any person other than the parties hereto and their respective heirs,  legal
representatives  and  successors,  any rights or remedies  under or by reason of
this Agreement.

                                       5
<PAGE>

      12.  HEADINGS.  The headings  contained herein are for the sole purpose of
convenience  of reference,  and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Agreement.

      13. SEVERABILITY. Any provision of this Agreement which is held by a court
of  competent   jurisdiction   to  be   prohibited  or   unenforceable   in  any
jurisdiction(s) shall be, as to such jurisdiction(s),  ineffective to the extent
of such  prohibition  or  unenforceability  without  invalidating  the remaining
provisions of this Agreement or affecting the validity or enforceability of such
provision in any other jurisdiction.

      14. JURISDICTION.  Each of the parties irrevocably agrees that any and all
suits or  proceedings  based on or arising  under this  Agreement may be brought
only in and shall be resolved in the federal or state courts located in the City
of Los Angeles,  California and consents to the  jurisdiction of such courts for
such  purpose.  Each  of  the  parties  irrevocably  waives  the  defense  of an
inconvenient  forum to the  maintenance  of such suit or  proceeding in any such
court.  Each of the parties  further  agrees that  service of process  upon such
party  mailed by first class mail to the address set forth in Section 9 shall be
deemed in every respect effective service of process upon such party in any such
suit or  proceeding.  Nothing  herein  shall affect the right of either party to
serve process in any other manner  permitted by law. Each of the parties  agrees
that a final  non-appealable  judgment in any such suit or  proceeding  shall be
conclusive and may be enforced in other  jurisdictions  by suit on such judgment
or in any other lawful manner.

      15. ATTORNEYS' FEES AND  DISBURSEMENTS.  If any action at law or in equity
is necessary to enforce or interpret the terms of this Agreement, the prevailing
party or parties  shall be entitled  to receive  from the other party or parties
reasonable  attorneys' fees and disbursements in addition to any other relief to
which the prevailing party or parties may be entitled.

             [The balance of this page is intentionally left blank.]

                                       6
<PAGE>

      IN WITNESS WHEREOF,  this Agreement has been executed and delivered by the
parties hereto as of the date first above written.

                                               GENETHERA, INC.

                                             By: /s/ Antonio Milici
                                             Name:  Antonio Milici
                                             Its:  Chief Executive Officer

                                             HOLDERS:

                                             MERCATOR MOMENTUM FUND, L.P.
                                             BY:  MERCATOR ADVISORY GROUP, LLC,
                                             GENERAL PARTNER

                                             By: /s/ David Firestone
                                             Name:  David Firestone
                                             Its:        Managing Member

                                             MERCATOR MOMENTUM FUND III, L.P.
                                             BY MERCATOR ADVISORY GROUP, LLC
                                             GENERAL PARTNER

                                             By: /s/ David Firestone
                                             Name: David Firestone
                                             Its: Managing Member

                                             MONARCH POINTE FUND, LTD.

                                             By: /s/ David Firestone
                                             Name: David Firestone
                                             Its:       President

                                             MERCATOR ADVISORY GROUP, LLC

                                             By: /s/ David Firestone
                                             Name: David Firestone
                                             Its:  Managing Member

                                       7EXHIBIT 10.3

THIS WARRANT AND THE  SECURITIES  ISSUABLE  HEREUNDER  HAVE NOT BEEN  REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY
MAY NOT BE SOLD,  OFFERED  FOR SALE,  PLEDGED OR  OTHERWISE  TRANSFERRED  IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE
STATE  SECURITIES  LAWS OR THE  AVAILABILITY  OF AN EXEMPTION FROM  REGISTRATION
UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

                        WARRANT TO PURCHASE COMMON STOCK

       NUMBER OF SHARES:          Up to 119,565 shares (subject to adjustment)
       WARRANT PRICE:             $0.92 per share
       ISSUANCE DATE:             January 18, 2005
       EXPIRATION DATE:           January 18, 2008
THIS WARRANT CERTIFIES THAT for value received, Mercator Advisory Group, LLC or
its registered assigns (hereinafter called the "HOLDER") is entitled to purchase
from GeneThera, Inc. (hereinafter called the "Company"), the above referenced
number of fully paid and nonassessable shares (the "SHARES") of common stock
(the "COMMON STOCK"), of Company, at the Warrant Price per Share referenced
above; the number of shares purchasable upon exercise of this Warrant referenced
above being subject to adjustment from time to time as described herein. This
Warrant is issued in connection with that certain Subscription Agreement dated
as of the date hereof, by and between the Company and Holder (the "SUBSCRIPTION
AGREEMENT"). The exercise of this Warrant shall be subject to the provisions,
limitations and restrictions contained herein.

1. TERM AND EXERCISE.

1.1 TERM. This Warrant is exercisable in whole or in part (but not as to any
fractional share of Common Stock), at any time and from time to time after the
date hereof prior to 6:00 p.m. on the Expiration Date set forth above.

1.2  WARRANT  PRICE.  The Warrant  shall be  exercisable  at the  Warrant  Price
described above.

1.3  MAXIMUM  NUMBER OF SHARES.  The  maximum  number of Shares of Common  Stock
exercisable pursuant to this Warrant is 119.565 Shares. However, notwithstanding
anything  herein to the  contrary,  in no event shall the Holder be permitted to
exercise this Warrant for a number of Shares  greater than the number that would
cause  the  aggregate   beneficial  ownership  of  the  Company's  Common  Stock
(calculated  pursuant to Rule 13d-3 of the  Securities  Exchange Act of 1934, as
amended) of (a) the Holder and its  affiliates or (b) Mercator  Advisory  Group,
LLC,  and its  affiliates,  to equal 9.99% of the  Company's  Common  Stock then
outstanding.

1.4  PROCEDURE  FOR  EXERCISE OF WARRANT.  Holder may  exercise  this Warrant by
delivering  the following to the  principal  office of the Company in accordance
with Section 5.1 hereof: (i) a duly executed Notice of Exercise in substantially
the form  attached  as Schedule  A, (ii)  payment of the  Warrant  Price then in
effect for each of the Shares being  purchased,  as  designated in the Notice of
Exercise,  and (iii) this Warrant.  Payment of the Warrant Price may be in cash,
certified or official  bank check  payable to the order of the Company,  or wire
transfer of funds to the  Company's  account (or any  combination  of any of the
foregoing) in the amount of the Warrant Price for each share being purchased.

1.5 DELIVERY OF CERTIFICATE AND NEW WARRANT. In the event of any exercise of the
rights represented by this Warrant, a certificate or certificates for the shares
of Common Stock so purchased, registered in the name of the Holder or such other
name or  names as may be  designated  by the  Holder,  together  with any  other
securities  or other  property  which the Holder is  entitled  to  receive  upon
exercise  of this  Warrant,  shall be  delivered  to the Holder  hereof,  at the
Company's expense, within a reasonable time, not exceeding fifteen (15) calendar
days, after the rights represented by this Warrant shall have been so exercised;
and, unless this Warrant has expired,  a new Warrant  representing the number of
Shares (except a remaining fractional share), if any, with respect to which this
Warrant  shall not then have been  exercised  shall also be issued to the Holder
hereof within such time. The person in whose name any  certificate for shares of
Common Stock is issued upon  exercise of this Warrant  shall for all purposes be
deemed to have  become the holder of record of such  shares on the date on which
the Warrant was surrendered and payment of the Warrant Price was received by the
Company, irrespective of the date of delivery of such certificate,  except that,
if the date of such  surrender and payment is on a date when the stock  transfer
books of the Company are closed,  such person shall be deemed to have become the
holder of such Shares at the close of business  on the next  succeeding  date on
which the stock transfer books are open.

1.6  RESTRICTIVE  LEGEND.  Each  certificate for Shares shall bear a restrictive
legend in substantially the form as follows, together with any additional legend
required by (i) any  applicable  state  securities  laws and (ii) any securities
exchange upon which such Shares may, at the time of such exercise, be listed:

      THE SHARES OF STOCK EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
      UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED,
      SOLD, PLEDGED OR OTHERWISE  TRANSFERRED  ("TRANSFERRED") IN THE ABSENCE OF
      SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM.  IN THE ABSENCE OF
      SUCH  REGISTRATION,  SUCH  SHARES MAY NOT BE  TRANSFERRED  UNLESS,  IF THE
      COMPANY REQUESTS,  THE COMPANY HAS RECEIVED A WRITTEN OPINION FROM COUNSEL
      IN FORM AND  SUBSTANCE  SATISFACTORY  TO THE  COMPANY  STATING  THAT  SUCH
      TRANSFER IS BEING MADE IN COMPLIANCE WITH ALL APPLICABLE FEDERAL AND STATE
      SECURITIES LAWS.

Any  certificate  issued  at any  time  in  exchange  or  substitution  for  any
certificate  bearing  such  legend  shall also bear such legend  unless,  in the
opinion of counsel for the Holder  thereof  (which  counsel  shall be reasonably
satisfactory  to the Company),  the securities  represented  thereby are not, at
such time, required by law to bear such legend.

1.7 FRACTIONAL  SHARES.  No fractional Shares shall be issuable upon exercise or
conversion of the Warrant. In the event of a fractional interest,  the number of
Shares to be issued shall be rounded down to the nearest whole Share.

                                     Page 1
<PAGE>

2. REPRESENTATIONS, WARRANTIES AND COVENANTS.

2.1 REPRESENTATIONS AND WARRANTIES.

      (a) The Company is a corporation  duly organized,  validly existing and in
good standing under the laws of its state of incorporation and has all necessary
power and authority to perform its obligations under this Warrant;

      (b) The execution,  delivery and performance of this Warrant has been duly
authorized by all necessary  actions on the part of the Company and  constitutes
the legal, valid and binding obligation of the Company,  enforceable against the
Company in accordance with its terms; and

      (c) This Warrant  does not violate and is not in conflict  with any of the
provisions  of  the  Company's  Articles  of  Incorporation  or  Certificate  of
Determination, Bylaws and any resolutions of the Company's Board of Directors or
stockholders,  or any agreement of the Company, and no event has occurred and no
condition or circumstance  exists that might (with or without notice or lapse of
time)  constitute  or result  directly  or  indirectly  in such a  violation  or
conflict.

2.2  ISSUANCE  OF SHARES.  The Company  covenants  and agrees that all shares of
Common Stock that may be issued upon the exercise of the rights  represented  by
this  Warrant  will,  upon  issuance,   be  validly   issued,   fully  paid  and
nonassessable,  and free from all taxes,  liens and charges  with respect to the
issue thereof.  The Company  further  covenants and agrees that it will pay when
due and  payable  any and all  federal  and state  taxes which may be payable in
respect  of the  issue of this  Warrant  or any  Common  Stock  or  certificates
therefor  issuable  upon the  exercise  of this  Warrant.  The  Company  further
covenants  and agrees that the  Company  will at all times have  authorized  and
reserved,  free from preemptive  rights, a sufficient number of shares of Common
Stock to provide  for the  exercise  in full of the rights  represented  by this
Warrant.  If at any time the number of authorized but unissued  shares of Common
Stock of the  Company  shall not be  sufficient  to effect the  exercise  of the
Warrant in full,  subject to the  limitations  set forth in Section  1.3 hereto,
then the Company will take all such  corporate  action as may, in the opinion of
counsel to the Company,  be necessary or advisable to increase the number of its
authorized  shares of Common Stock as shall be sufficient to permit the exercise
of the  Warrant in full,  subject to the  limitations  set forth in Section  1.3
hereto,  including  without  limitation,  using its best  efforts  to obtain any
necessary  stockholder  approval of such increase.  If and so long as the Common
Stock  issuable  upon the  exercise  of this  Warrant is listed on any  national
securities  exchange or the Nasdaq Stock Market,  the Company will, if permitted
by the rules of such  exchange or market,  list and keep listed on such exchange
or market,  upon  official  notice of issuance,  all shares of such Common Stock
issuable upon exercise of this Warrant.

3. OTHER ADJUSTMENTS.

3.1 SUBDIVISION OR COMBINATION OF SHARES.  In case the Company shall at any time
subdivide  its  outstanding  Common Stock into a greater  number of shares,  the
Warrant  Price  in  effect  immediately  prior  to  such  subdivision  shall  be
proportionately  reduced, and the number of Shares subject to this Warrant shall
be  proportionately  increased,  and conversely,  in case the outstanding Common
Stock of the Company  shall be  combined  into a smaller  number of shares,  the
Warrant  Price  in  effect  immediately  prior  to  such  combination  shall  be
proportionately  increased,  and the number of Shares  subject  to this  Warrant
shall be proportionately decreased.

3.2 DIVIDENDS IN COMMON STOCK,  OTHER STOCK OR PROPERTY.  If at any time or from
time to time the  holders  of  Common  Stock  (or any  shares  of stock or other
securities at the time  receivable upon the exercise of this Warrant) shall have
received or become entitled to receive, without payment therefor:

      (a) Common Stock,  Options or any shares or other  securities which are at
any time  directly or indirectly  convertible  into or  exchangeable  for Common
Stock, or any rights or options to subscribe for,  purchase or otherwise acquire
any of the foregoing by way of dividend or other distribution;

      (b) any cash paid or payable otherwise than as a regular cash dividend; or

      (c) Common  Stock or  additional  shares or other  securities  or property
(including cash) by way of spin-off, split-up, reclassification,  combination of
shares or similar corporate  rearrangement  (other than Common Stock issued as a
stock split or  adjustments in respect of which shall be covered by the terms of
Section 3.1 above) and additional shares, other securities or property issued in
connection with a Change (as defined below) (which shall be covered by the terms
of Section 3.4 below), then and in each such case, the Holder hereof shall, upon
the exercise of this Warrant,  be entitled to receive, in addition to the number
of shares of Common  Stock  receivable  thereupon,  and  without  payment of any
additional  consideration therefor, the amount of stock and other securities and
property  (including  cash in the cases referred to in clause (b) above and this
clause (c)) which such Holder  would hold on the date of such  exercise had such
Holder  been the holder of record of such  Common  Stock as of the date on which
holders of Common  Stock  received or became  entitled to receive such shares or
all other additional stock and other securities and property.

3.3  REORGANIZATION,  RECLASSIFICATION,  CONSOLIDATION,  MERGER OR SALE.  If any
recapitalization, reclassification or reorganization of the share capital of the
Company, or any consolidation or merger of the Company with another corporation,
or the sale of all or  substantially  all of its shares  and/or  assets or other
transaction (including,  without limitation,  a sale of substantially all of its
assets  followed by a liquidation)  shall be effected in such a way that holders
of Common Stock shall be entitled to receive shares,  securities or other assets
or property  (a  "Change"),  then,  as a condition  of such  Change,  lawful and
adequate provisions shall be made by the Company whereby the Holder hereof shall
thereafter  have the right to purchase  and receive (in lieu of the Common Stock
of the Company  immediately  theretofore  purchasable  and  receivable  upon the
exercise of the rights  represented  hereby)  such shares,  securities  or other
assets or  property as may be issued or payable  with  respect to or in exchange
for the number of  outstanding  Common  Stock which such Holder  would have been
entitled to receive had such Holder exercised this Warrant  immediately prior to
the  consummation  of such Change.  The Company or its successor  shall promptly
issue to Holder a new Warrant for such new securities or other property. The new
Warrant shall provide for adjustments which shall be as nearly equivalent as may
be practicable to give effect to the adjustments  provided for in this Section 3
including,  without  limitation,  adjustments  to the  Warrant  Price and to the
number of securities or property issuable upon exercise of the new Warrant.  The
provisions of this Section 3.3 shall similarly apply to successive Changes.

4. OWNERSHIP AND TRANSFER.

4.1  OWNERSHIP  OF THIS  WARRANT.  The  Company may deem and treat the person in
whose  name  this  Warrant  is   registered  as  the  holder  and  owner  hereof
(notwithstanding  any  notations of  ownership or writing  hereon made by anyone
other than the Company) for all purposes and shall not be affected by any notice
to the contrary until  presentation of this Warrant for registration of transfer
as provided in this Section 4.

4.2 TRANSFER AND REPLACEMENT.  Subject to restrictions on transferability  under
applicable   securities   laws,  this  Warrant  and  all  rights  hereunder  are
transferable  in whole or in part upon the books of the  Company  by the  Holder
hereof in person or by duly authorized attorney,  and a new Warrant or Warrants,
of the same tenor as this Warrant but  registered in the name of the  transferee
or  transferees  (and in the  name  of the  Holder,  if a  partial  transfer  is
effected)  shall be made and  delivered  by the Company  upon  surrender of this
Warrant duly endorsed,  at the office of the Company in accordance  with Section
5.1 hereof. Upon receipt by the Company of evidence  reasonably  satisfactory to
it of the loss,  theft or  destruction,  and,  in such  case,  of  indemnity  or
security  reasonably  satisfactory  to it, and upon surrender of this Warrant if
mutilated,  the Company  will make and  deliver a new Warrant of like tenor,  in
lieu of this Warrant;  provided that if the Holder hereof is an  instrumentality
of a state or local government or an institutional  holder or a nominee for such
an instrumentality or institutional holder an irrevocable agreement of indemnity
by such Holder  shall be  sufficient  for all purposes of this  Warrant,  and no
evidence of loss or theft or destruction shall be necessary.  This Warrant shall
be promptly  cancelled by the Company upon the  surrender  hereof in  connection
with any transfer or  replacement.  Except as otherwise  provided  above, in the
case of the loss,  theft or destruction of a Warrant,  the Company shall pay all
expenses,  taxes and other charges  payable in  connection  with any transfer or
replacement  of this Warrant,  other than income taxes and stock  transfer taxes
(if any) payable in connection  with a transfer of this Warrant,  which shall be
payable by the Holder.  Holder  will not  transfer  this  Warrant and the rights
hereunder except in compliance with federal and state securities laws and except
after  providing  evidence of such  compliance  reasonably  satisfactory  to the
Company.

                                     Page 2
<PAGE>

5. MISCELLANEOUS PROVISIONS.

5.1 NOTICES.  Any notice or other document  required or permitted to be given or
delivered  to the Holder  shall be  delivered  or forwarded to the Holder at c/o
Mercator Advisory Group, LLC, 555 South Flower Street,  Suite 4200, Los Angeles,
California 90071, Attention: David F. Firestone (Facsimile No. 213/553-8285), or
to such other  address or number as shall have been  furnished to the Company in
writing by the Holder, with a copy to Sheppard Mullin Richter & Hampton LLP, 333
South Hope Street,  48th Floor,  Los Angeles,  California  90071-1448  Attention
David C.  Ulich  (Facsimile  No.  213/620-1398).  Any  notice or other  document
required or permitted to be given or delivered to the Company shall be delivered
or forwarded to the Company at GeneThera,  Inc., 3930 Youngfield  Street,  Wheat
Ridge, Colorado 80033, Attention:  Antonio Milici (Facsimile No. (303) 463-6377)
with a copy to Kendall,  Koenig & Oelsner PC, 1675 Broadway,  Suite 750, Denver,
CO 80202 Attention:  Nathan E. Seiler (Facsimile No. (303) 672-0101), or to such
other address or number as shall have been furnished to Holder in writing by the
Company.

5.2 All notices,  requests and  approvals  required by this Warrant  shall be in
writing and shall be conclusively  deemed to be given (i) when hand-delivered to
the other  party,  (ii) when  received if sent by  facsimile  at the address and
number set forth above;  provided that notices  given by facsimile  shall not be
effective,  unless  either  (a) a  duplicate  copy of such  facsimile  notice is
promptly given by depositing the same in the mail, postage prepaid and addressed
to the party as set forth below or (b) the  receiving  party  delivers a written
confirmation of receipt for such notice by any other method permitted under this
paragraph;  and further  provided  that any notice given by  facsimile  received
after  5:00 p.m.  (recipient's  time) or on a  non-business  day shall be deemed
received on the next business day; (iii) five (5) business days after deposit in
the United States mail,  certified,  return receipt requested,  postage prepaid,
and  addressed  to the party as set forth below;  or (iv) the next  business day
after deposit with an international overnight delivery service, postage prepaid,
addressed  to the  party as set forth  below  with next  business  day  delivery
guaranteed;  provided that the sending party receives  confirmation  of delivery
from the delivery service provider.

5.3 NO RIGHTS AS  SHAREHOLDER;  LIMITATION OF LIABILITY.  This Warrant shall not
entitle the Holder to any of the rights of a shareholder  of the Company  except
upon exercise in accordance with the terms hereof.  No provision  hereof, in the
absence of affirmative  action by the Holder to purchase shares of Common Stock,
and no mere enumeration herein of the rights or privileges of the Holder,  shall
give rise to any liability of the Holder for the Warrant Price hereunder or as a
shareholder of the Company, whether such liability is asserted by the Company or
by creditors of the Company.

5.4 GOVERNING LAW. This Warrant shall be governed by and construed in accordance
with  the  laws of the  State of  California  as  applied  to  agreements  among
California  residents  made and to be  performed  entirely  within  the State of
California, without giving effect to the conflict of law principles thereof.

5.5  BINDING  EFFECT ON  SUCCESSORS.  This  Warrant  shall be  binding  upon any
corporation  succeeding the Company by merger,  consolidation  or acquisition of
all or substantially all of the Company's assets and/or  securities.  All of the
obligations of the Company  relating to the Shares issuable upon the exercise of
this Warrant shall survive the exercise and termination of this Warrant.  All of
the  covenants  and  agreements of the Company shall inure to the benefit of the
successors and assigns of the Holder.

5.6 WAIVER,  AMENDMENTS AND HEADINGS.  This Warrant and any provision hereof may
be changed,  waived,  discharged or terminated  only by an instrument in writing
signed by both parties (either generally or in a particular  instance and either
retroactively or  prospectively).  The headings in this Warrant are for purposes
of reference only and shall not affect the meaning or construction of any of the
provisions hereof.

5.7 JURISDICTION.  Each of the parties irrevocably agrees that any and all suits
or  proceedings  based on or arising under this Agreement may be brought only in
and shall be resolved in the federal or state courts  located in the City of Los
Angeles,  California  and consents to the  jurisdiction  of such courts for such
purpose.  Each of the parties  irrevocably waives the defense of an inconvenient
forum to the  maintenance of such suit or proceeding in any such court.  Each of
the parties  further  agrees that  service of process  upon such party mailed by
first  class mail to the  address  set forth in  Section  5.1 shall be deemed in
every respect  effective  service of process upon such party in any such suit or
proceeding.  Nothing  herein  shall  affect  the right of either  party to serve
process in any other manner  permitted by law. Each of the parties agrees that a
final non-appealable judgment in any such suit or proceeding shall be conclusive
and may be enforced in other  jurisdictions  by suit on such  judgment or in any
other lawful manner.

5.8  ATTORNEYS'  FEES AND  DISBURSEMENTS.  If any  action at law or in equity is
necessary to enforce or interpret the terms of this  Agreement,  the  prevailing
party or parties  shall be entitled  to receive  from the other party or parties
reasonable  attorneys' fees and disbursements in addition to any other relief to
which the prevailing party or parties may be entitled.

                                     Page 3
<PAGE>

IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
authorized officer this 18th day of January, 2005.

COMPANY:
                                                    GENETHERA, INC.

                                                    BY /S/ ANTONIO MILICI

                                                    PRINT NAME:  ANTONIO MILICI

                                                    TITLE: CHAIRMAN AND CEO

                                     Page 4
<PAGE>

                                   SCHEDULE A

                           FORM OF NOTICE OF EXERCISE

                [TO BE SIGNED ONLY UPON EXERCISE OF THE WARRANT]

                     TO BE EXECUTED BY THE REGISTERED HOLDER
                         TO EXERCISE THE WITHIN WARRANT

The  undersigned  hereby elects to purchase  _______ shares of Common Stock (the
"Shares") of GeneThera,  Inc.  under the Warrant to Purchase  Common Stock dated
January __ , 2005, which the undersigned is entitled to purchase pursuant to the
terms of such Warrant. The undersigned has delivered  $_________,  the aggregate
Warrant  Price  for  _____  Shares  purchased  herewith,  in  full in cash or by
certified or official bank check or wire transfer.

      Please issue a certificate  or  certificates  representing  such shares of
Common  Stock  in the  name  of the  undersigned  or in  such  other  name as is
specified below and in the denominations as is set forth below:

        ________________________________________________________________________
        [Type Name of Holder as it should appear on the stock certificate]

        ________________________________________________________________________
        [Requested Denominations - if no denomination is specified, a single
        certificate will be issued]

      The  initial  address of such Holder to be entered on the books of Company
shall be:

        ________________________________________________________________________

        ________________________________________________________________________

        ________________________________________________________________________

      The  undersigned  hereby  represents and warrants that the  undersigned is
acquiring such shares for his own account for investment  purposes only, and not
for resale or with a view to distribution of such shares or any part thereof.

                                    By:
                                       -----------------------------------------

                                    Print Name:
                                               ---------------------------------

                                    Title:
                                          --------------------------------------

                                    Dated:
                                          --------------------------------------

                                     Page 5
<PAGE>

                               FORM OF ASSIGNMENT
                                    (ENTIRE)

               [TO BE SIGNED ONLY UPON TRANSFER OF ENTIRE WARRANT]

                     TO BE EXECUTED BY THE REGISTERED HOLDER
                         TO TRANSFER THE WITHIN WARRANT

FOR  VALUE  RECEIVED   ___________________________  hereby  sells,  assigns  and
transfers  unto  _______________________________  all rights of the  undersigned
under and  pursuant  to the within  Warrant,  and the  undersigned  does  hereby
irrevocably  constitute and appoint  _____________________  Attorney to transfer
the said  Warrant  on the  books  of  ________  _________,  with  full  power of
substitution.

_______________________________________
[Type Name of Holder]

By: ___________________________________

Title:_________________________________

Dated:_________________________________

NOTICE

The signature to the foregoing Assignment must correspond exactly to the name as
written upon the face of the within Warrant,  without  alteration or enlargement
or any change whatsoever.

                                       -1-
<PAGE>

                               FORM OF ASSIGNMENT
                                    (PARTIAL)

              [TO BE SIGNED ONLY UPON PARTIAL TRANSFER OF WARRANT]

                     TO BE EXECUTED BY THE REGISTERED HOLDER
                         TO TRANSFER THE WITHIN WARRANT

FOR  VALUE  RECEIVED   ___________________________  hereby  sells,  assigns  and
transfers unto ____________________________ (i) the rights of the undersigned to
purchase  ____________________  shares of Common Stock under and pursuant to the
within  Warrant,  and (ii) on a  non-exclusive  basis,  all other  rights of the
undersigned  under and pursuant to the within Warrant,  it being understood that
the undersigned shall retain, severally (and not jointly) with the transferee(s)
named herein, all rights assigned on such  non-exclusive  basis. The undersigned
does  hereby  irrevocably  constitute  and  appoint   __________________________
Attorney to transfer  the said  Warrant on the books of  GeneThera , Inc.,  with
full power of substitution.

[Type Name of Holder]

By:
     ------------------------------------------
Title:
     ------------------------------------------

Dated:
        ---------------------------------------

NOTICE

The signature to the foregoing Assignment must correspond exactly to the name as
written upon the face of the within Warrant,  without  alteration or enlargement
or any change whatsoever.

                                       -2-
<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]